A nomogram to predict early postoperative recurrence of hepatocellular carcinoma with portal vein tumour thrombus after R0 liver resection: A large-scale, multicenter study. Issue 9 (September 2019)

• Record Type: Journal Article
• Authors: Zhang, Xiu-Ping; Chen, Zhen-Hua; Zhou, Teng-Fei; Li, Le-Qun; Chen, Min-Shan; Wen, Tian-Fu; Shi, Jie; Guo, Wei-Xing; Wu, Meng-Chao; Lau, Wan Yee; Cheng, Shu-Qun
• Is Part Of: European journal of surgical oncology. Volume 45:Issue 9(2019)
• Page Start: 1644
• Page End: 1651
• Publication Date: 2019-09
• Subjects: Hepatocellular carcinoma -- Portal vein tumour thrombus -- R0 liver resection -- Nomogram -- Early recurrence; HCC hepatocellular carcinoma -- PVTT portal vein tumour thrombus -- LR liver resection -- ER early recurrence.; Oncology -- Periodicals; Cancer -- Surgery -- Periodicals; Medical Oncology -- Periodicals; Neoplasms -- surgery -- Periodicals; Cancer -- Chirurgie -- Périodiques; Cancérologie -- Périodiques; Oncologie; Chirurgie (geneeskunde); Electronic journals; Electronic journals -- Sciences; Electronic journals -- Medicine; Electronic journals; 616.994059005
• DOI: 10.1016/j.ejso.2019.03.043
• Languages: English
• ISSNs: 0748-7983

Abstract

Abstract: Background: Portal vein tumour thrombus (PVTT) is a significant poor prognostic factor for hepatocellular carcinoma (HCC). Patients with PVTT limited to a first-order branch or above of the main portal vein (MPV) could benefit from R0 liver resection (LR). A nomogram is needed to predict early postoperative recurrence (ER) in HCC patients with PVTT and to guide selection of these patients for adjuvant therapy to reduce postoperative recurrence risks. Methods: HCC patients with PVTT limited to a first-order branch or above of the MPV after R0 LR as an initial therapy were included. A nomogram using data from a retrospective training cohort was developed with the Cox regression model. The model was tested in a prospective internal validation cohort and three external validation cohorts. Results: Of 979 patients, 657 developed postoperative ER (67.1%). ER occurred in 165 of 264 patients (62.5%) in the training cohort, 146 of 218 patients (70.0%) in the internal validation cohort, and 204 of 284 patients (71.8%), 77 of 113 patients (68.1%), and 65 of 100 patients (65%) in the three external validation cohorts, respectively. The nomogram included the following variables: hepatitis B surface antigen (HBsAg), PVTT, HBV DNA, satellite nodules, α-fetoprotein, and tumour diameter. The ROC were 0.836, 0.763, 0.802, 0.837, and 0.846 in predicting ER in the five respective cohorts. Conclusion: A nomogram was developed and validated to predict postoperative ER in patients with HCC with PVTT after R0 LR. This nomogram could select appropriate patients with high ER risks for postoperative adjuvant therapy.